NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) Preferred Stock Liabilities (2018 - 2020)

Updated

NovaBridge Biosciences (NBP) posted Preferred Stock Liabilities of $921.24 million for Q4 2020, up 107.3% from $444.36 million a year earlier.

Analysis

NovaBridge Biosciences (NBP) Preferred Stock Liabilities (2018 - 2020) Analysis & Trends

Since Q4 2018, NovaBridge Biosciences has reported Preferred Stock Liabilities for 4 quarters.

  • In prior years, NovaBridge Biosciences' Preferred Stock Liabilities was $445.89 million in FY2019 (+5.2%) and $423.92 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 687.48 Mn
Jun 30, 2020 687.48 Mn
Dec 31, 2019 444.36 Mn
Dec 31, 2018 423.92 Mn
API Access

NovaBridge Biosciences Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=NBP&period=max&api_key=YOUR_API_KEY